Series B funding round for Cambridge Epigenetix raising $21M in March 2016
Series B funding round for Cambridge Epigenetix raising $21M in March 2016
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Nikolaj Nyholm |
| Angel | Dharmesh Shah |
| Angel | Pete Moore |
| Angel | Erik Nordlander |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$139M
Top Valuation
-
Cambridge Epigenetix raised $21M in a Series B round.
The round was announced on 03/01/16.